The role of eating styles in diabetes control
New research reveals that patients who eat in response to food cues lose more weight on GLP-1 therapy,…
How processed red meat might drive neurodegenerative diseases
Scientists warn that while processed red meat may fuel harmful brain changes linked to Alzheimer’s, Parkinson’s, and ALS,…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Fitness study shows exercise at work can cut chronic disease risks
A new Italian study finds that just two weekly workplace workouts can lower cholesterol and blood pressure, proving…
Antibody cocktail could change the way the world fights influenza
An unusual therapy developed at The Jackson Laboratory (JAX) could change the way the world fights influenza, one…
Ablation methods equally effective for drug-resistant paroxysmal atrial fibrillation
Pulsed field ablation did not have superior efficacy to radiofrequency ablation in patients with drug-resistant paroxysmal (intermittent) atrial…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…
Probiotic enhances cholesterol drug efficacy but raises safety concerns at high doses
A recent study published in Engineering has shed light on the complex interactions between probiotics and drugs, particularly…
How a single gene reshapes pain perception through polyamine signaling
A breakthrough discovery reveals how the SLC45A4 gene fine-tunes polyamine transport in sensory neurons, reshaping our understanding of…
GIPR signaling opens brain’s gate for GLP-1 weight-loss therapy
A new study uncovers how GIPR signaling in brain cells helps GLP-1 weight-loss drugs bypass the blood-brain barrier…
Griffith University launches groundbreaking treatment trial for spinal cord injury
A Phase 1 human clinical trial to treat chronic spinal cord injury, the first of its kind in…